Jianfei Qian

Jianfei Qian

UNVERIFIED PROFILE

Are you Jianfei Qian?   Register this Author

Register author
Jianfei Qian

Jianfei Qian

Publications by authors named "Jianfei Qian"

Are you Jianfei Qian?   Register this Author

51Publications

840Reads

28Profile Views

Cholesterol Induces CD8 T Cell Exhaustion in the Tumor Microenvironment.

Cell Metab 2019 Jul 25;30(1):143-156.e5. Epub 2019 Apr 25.

Center for Translational Research in Hematologic Malignancies, Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmet.2019.04.002DOI Listing
July 2019

E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs.

J Clin Invest 2018 11 2;128(11):4821-4831. Epub 2018 Oct 2.

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI121421DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205396PMC
November 2018

Cholesterol negatively regulates IL-9-producing CD8 T cell differentiation and antitumor activity.

J Exp Med 2018 06 9;215(6):1555-1569. Epub 2018 May 9.

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20171576DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987919PMC
June 2018

Th9 Cells Represent a Unique Subset of CD4 T Cells Endowed with the Ability to Eradicate Advanced Tumors.

Cancer Cell 2018 06;33(6):1048-1060.e7

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2018.05.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072282PMC
June 2018

Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of T9 cells programmed by IL-7.

Sci Signal 2017 Oct 10;10(500). Epub 2017 Oct 10.

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scisignal.aak9741DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961737PMC
October 2017

Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.

J Natl Cancer Inst 2016 11 5;108(11). Epub 2016 Jul 5.

Affiliations of authors: Department of Hematology and State Key Laboratory of Biotherapy and Cancer Center, Sichuan University, West China Hospital, China (YZ); Department of Cancer Biology (YZ, QW, TL, JQ, YLu, YLi, EB, QY), Taussig Cancer Center (FR), Imaging Core Facility, Lerner Research Institute (JD), and Department of Pathology and Laboratory Medicine Institute (EH), Cleveland Clinic, Cleveland, OH; Department of Hematology, Zhejiang University, China (YLi, ZC); Department of Internal Medicine, Weiss Memory Hospital, Chicago, IL (YQ); Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX (JY).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241902PMC
November 2016

IL-15 enhances the antitumor effect of human antigen-specific CD8 T cells by cellular senescence delay.

Oncoimmunology 2016 7;5(12):e1237327. Epub 2016 Oct 7.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1237327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215241PMC
October 2016

CD4⁺ T cells play a crucial role for lenalidomide in vivo anti-tumor activity in murine multiple myeloma.

Oncotarget 2015 Nov;6(34):36032-40

Department of Lymphoma/Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.5506DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742159PMC
November 2015

Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma.

Oncotarget 2015 Sep;6(27):24218-29

Bone Marrow Transplantation Center, Department of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.4523DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695181PMC
September 2015

Anti-β₂-microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagy.

Oncotarget 2015 Apr;6(11):8567-78

Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496167PMC
http://dx.doi.org/10.18632/oncotarget.3251DOI Listing
April 2015

p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion.

Int J Cancer 2015 Jan 16;136(1):34-43. Epub 2014 May 16.

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28958DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200482PMC
January 2015

Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells on osteoclastogenesis by upregulating the RANK expression.

PLoS One 2013 10;8(12):e82453. Epub 2013 Dec 10.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas M D Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0082453PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858321PMC
September 2014

Anti-β₂M monoclonal antibodies kill myeloma cells via cell- and complement-mediated cytotoxicity.

Int J Cancer 2014 Sep 7;135(5):1132-41. Epub 2014 Feb 7.

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28745DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230340PMC
September 2014

Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma.

Br J Haematol 2014 Sep 14;166(5):690-701. Epub 2014 May 14.

Myeloma & Lymphoma Centre, Department of Haematology, Changzheng Hospital, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12943DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134698PMC
September 2014

A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance.

Blood 2014 Sep 21;124(13):2061-71. Epub 2014 Jul 21.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2014-03-55
Publisher Site
http://dx.doi.org/10.1182/blood-2014-03-557298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186536PMC
September 2014

Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy.

Cancer Immunol Immunother 2014 Aug 20;63(8):835-45. Epub 2014 May 20.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, and Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-014-1557-4
Publisher Site
http://dx.doi.org/10.1007/s00262-014-1557-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200484PMC
August 2014

Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice.

Nat Med 2014 Jun 25;20(6):676-81. Epub 2014 May 25.

1] Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [2] Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [3] The University of Texas Graduate School of Biomedical Sciences, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.3560DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048321PMC
June 2014

USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.

Mol Cancer 2014 May 31;13:132. Epub 2014 May 31.

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue/NB40, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-13-132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057584PMC
May 2014

Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers.

Proc Natl Acad Sci U S A 2014 Feb 27;111(6):2265-70. Epub 2014 Jan 27.

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1317431111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926063PMC
February 2014

In vitro and in vivo therapeutic efficacy of carfilzomib in mantle cell lymphoma: targeting the immunoproteasome.

Mol Cancer Ther 2013 Nov 29;12(11):2494-504. Epub 2013 Aug 29.

Corresponding Authors: Liang Zhang, Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 0903, Houston, TX 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0156DOI Listing
November 2013

Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells.

Haematologica 2013 Sep 18;98(9):1458-66. Epub 2013 Mar 18.

Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2012.071340DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762104PMC
September 2013

Toll-like receptor-4 signaling in mantle cell lymphoma: effects on tumor growth and immune evasion.

Cancer 2013 Feb 22;119(4):782-91. Epub 2012 Aug 22.

Department of Lymphoma/Myeloma, Center for Cancer Immunology Research, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27792DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211879PMC
February 2013

p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction.

Cancer Res 2012 Dec 11;72(24):6393-402. Epub 2012 Oct 11.

Department of Lymphoma/Myeloma, Division of Cancer Medicine and Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-2664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525770PMC
December 2012

Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells.

Blood 2012 Nov 11;120(18):3783-92. Epub 2012 Sep 11.

Department of Lymphoma/Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-04-42
Publisher Site
http://dx.doi.org/10.1182/blood-2012-04-424630DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488890PMC
November 2012

Th9 cells promote antitumor immune responses in vivo.

J Clin Invest 2012 Nov 15;122(11):4160-71. Epub 2012 Oct 15.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, and Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://www.jci.org/articles/view/65459
Publisher Site
http://dx.doi.org/10.1172/JCI65459DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484462PMC
November 2012

DKK1 as a novel target for myeloma immunotherapy.

Oncoimmunology 2012 Aug;1(5):756-758

Department of Lymphoma/Myeloma; Division of Cancer Medicine; Center for Cancer Immunology Research; The University of Texas MD Anderson Cancer Center; Houston, TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.19655DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429585PMC
August 2012

Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone.

J Mol Med (Berl) 2012 Jun 30;90(6):695-706. Epub 2011 Dec 30.

Department of Lymphoma/Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00109-011-0849-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212830PMC
June 2012

CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma.

Cancer Immunol Immunother 2012 Apr 15;61(4):561-71. Epub 2011 Oct 15.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 0903, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-011-1123-2
Publisher Site
http://dx.doi.org/10.1007/s00262-011-1123-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810206PMC
April 2012

Combination of atiprimod and the proteasome inhibitor bortezomib induces apoptosis of mantle cell lymphoma in vitro and in vivo.

Leuk Res 2012 Mar 13;36(3):363-8. Epub 2011 Oct 13.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01452126110045
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2011.09.014DOI Listing
March 2012

Targeting cell surface β2 -microglobulin by pentameric IgM antibodies.

Br J Haematol 2011 Jul 9;154(1):111-21. Epub 2011 May 9.

Department of Lymphoma/Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2011.08714.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111817PMC
July 2011

Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells.

Blood 2010 Jul 19;116(2):210-7. Epub 2010 Mar 19.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, and Center for Cancer Immunology Research, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2009-11-25
Publisher Site
http://dx.doi.org/10.1182/blood-2009-11-255026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910608PMC
July 2010

Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.

Blood 2009 Oct 4;114(18):3880-9. Epub 2009 Aug 4.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, and Center for Cancer Immunology Research, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2009-06-22
Publisher Site
http://dx.doi.org/10.1182/blood-2009-06-227355DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773487PMC
October 2009

Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis.

Blood 2009 Oct 26;114(17):3625-8. Epub 2009 Aug 26.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2009-05-22
Publisher Site
http://dx.doi.org/10.1182/blood-2009-05-220285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766678PMC
October 2009

Human-like mouse models for testing the efficacy and safety of anti-beta2-microglobulin monoclonal antibodies to treat myeloma.

Clin Cancer Res 2009 Feb;15(3):951-9

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1823DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659684PMC
February 2009

Roles of idiotype-specific t cells in myeloma cell growth and survival: Th1 and CTL cells are tumoricidal while Th2 cells promote tumor growth.

Cancer Res 2008 Oct;68(20):8456-64

Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575640PMC
http://dx.doi.org/10.1158/0008-5472.CAN-08-2213DOI Listing
October 2008

A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma.

Clin Cancer Res 2008 Apr;14(7):2154-60

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-4409DOI Listing
April 2008

Anti beta2-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid rafts.

Blood 2007 Oct 20;110(8):3028-35. Epub 2007 Jul 20.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, and Center for Cancer Immunology Research, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-06-094417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2018676PMC
October 2007

Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.

Blood 2007 Sep 21;110(5):1587-94. Epub 2007 May 21.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, and the Center for Cancer Immunology Research, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-03-082529DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1975842PMC
September 2007

Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis.

Cancer Cell 2007 Sep;12(3):252-65

Department of Lymphoma and Myeloma, Division of Cancer Medicine, and the Center for Cancer Immunology Research, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S153561080700235
Publisher Site
http://dx.doi.org/10.1016/j.ccr.2007.08.008DOI Listing
September 2007

Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways.

Blood 2007 Jun 22;109(12):5455-62. Epub 2007 Feb 22.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-12-063958DOI Listing
June 2007

Dendritic cell vaccine but not idiotype-KLH protein vaccine primes therapeutic tumor-specific immunity against multiple myeloma.

Front Biosci 2007 May 1;12:3566-75. Epub 2007 May 1.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, and the Center for Cancer Immunology Research, The University of Texas M. D. Anderson Cancer, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/2335DOI Listing
May 2007

Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells.

Blood 2006 Dec 17;108(13):4071-7. Epub 2006 Aug 17.

Department of Lymphoma and Myeloma, Center for Cancer Immunology Research, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-04-016980DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895445PMC
December 2006

Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies.

Cancer Cell 2006 Oct;10(4):295-307

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2006.08.025DOI Listing
October 2006

Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.

Clin Cancer Res 2005 Dec;11(24 Pt 1):8808-15

Myeloma Institute for Research and Therapy, Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-1553DOI Listing
December 2005

Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38.

J Immunol 2003 Nov;171(9):4792-800

Myeloma Institute for Research and Therapy and Arkansas Cancer Research Center, Little Rock 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.171.9.4792DOI Listing
November 2003